Literature DB >> 20832344

A randomized study comparing isotope and echocardiography stress testing in the screening of silent myocardial ischaemia in type 2 diabetic patients.

S Jacqueminet1, O Barthelemy, F Rouzet, R Isnard, M Halbron, A Bouzamondo, D Le Guludec, A Grimaldi, J-P Metzger, C Le Feuvre.   

Abstract

AIMS: This study aimed to compare the positive predictive value (PPV) of stress myocardial scintigraphy (SPECT) and of dobutamine echocardiography (DE) in the diagnosis of significant coronary artery stenosis (CAD) in asymptomatic type 2 diabetic patients, and to assess long-term clinical outcomes according to silent myocardial ischaemia (SMI) screening.
METHODS: A total of 204 asymptomatic type 2 diabetic patients at high cardiovascular (CV) risk were prospectively randomized to undergo either SPECT (n=104) or DE (n=100). Coronary angiography was proposed in cases of SMI, with revascularization of suitable lesions. Intensive treatment of CV risk factors was prescribed for all patients. Death and myocardial infarction (MI) were recorded during the 3-year follow-up.
RESULTS: Clinical characteristics were similar in the two testing groups. The prevalence of SMI and significant CAD were 13% and 4%, respectively, in the SPECT group vs 11% and 5%, respectively, in the DE group (not significant [NS]). The PPV for the detection of significant CAD was 29% for SPECT and 45% for DE (NS). Seven patients (3%) underwent initial revascularization. The 3-year rate of CV death and MI was 2.5%, and similar in both groups.
CONCLUSION: Rates of SMI and significant CAD in asymptomatic high-risk type 2 diabetic patients receiving intensive care of risk factors are low, and SPECT and DE are similar in the detection of SMI and CAD. Coronary revascularization and intensive CV risk-factor therapy are associated with a low rate of adverse CV events at 3 years, whichever stress test was used.
Copyright © 2010 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20832344     DOI: 10.1016/j.diabet.2010.06.005

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  4 in total

Review 1.  Clinical review: Screening for coronary artery disease in type 2 diabetes.

Authors:  Charles T Upchurch; Eugene J Barrett
Journal:  J Clin Endocrinol Metab       Date:  2012-03-14       Impact factor: 5.958

2.  Relationship between silent myocardial ischemia and coronary artery disease risk factors.

Authors:  Saurabh Malhotra; Ravi Sharma; Dustin E Kliner; William P Follansbee; Prem Soman
Journal:  J Nucl Cardiol       Date:  2013-05-30       Impact factor: 5.952

Review 3.  Identification of coronary heart disease in asymptomatic individuals with diabetes mellitus: to screen or not to screen.

Authors:  Paco E Bravo; Bruce M Psaty; Marcelo F Di Carli; Kelley R Branch
Journal:  Colomb Med (Cali)       Date:  2015-03-30

4.  Asymptomatic myocardial ischemia forecasts adverse events in cardiovascular magnetic resonance dobutamine stress testing of high-risk middle-aged and elderly individuals.

Authors:  R Brandon Stacey; Trinity Vera; Timothy M Morgan; Jennifer H Jordan; Matthew C Whitlock; Michael E Hall; Sujethra Vasu; Craig Hamilton; Dalane W Kitzman; W Gregory Hundley
Journal:  J Cardiovasc Magn Reson       Date:  2018-11-22       Impact factor: 5.364

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.